In summary, many factors are involved in the variable response of asthma patients to SARS-CoV-2 infection, including the asthma phenotype, the corticosteroid treatment regimen and the role of cytokines such as IL-33 and IL-13 in potentiating the T2-high response. The gene discussed is IL33; the disease is asthma.